Abstract
Information about drug metabolism is an essential component of drug development. Modeling the drug metabolism requires identification of the involved enzymes, rate and extent of metabolism, the sites of metabolism etc. There has been continuous attempts in the prediction of metabolism of drugs using artificial intelligence in effort to reduce the attrition rate of drug candidates entering to preclinical and clinical trials. Currently, there are number of predictive models available for metabolism using Support vector machines, Artificial neural networks, Bayesian classifiers etc. There is an urgent need to review their progress so far and address the existing challenges in prediction of metabolism. In this attempt, we are presenting the currently available literature models and some of the critical issues regarding prediction of drug metabolism.
Keywords: Artificial intelligence, drug designing, drug metabolism, machine learning, pharmacokinetics, prediction.
Current Drug Metabolism
Title:Prediction of Metabolism of Drugs using Artificial Intelligence: How far have we reached?
Volume: 17 Issue: 2
Author(s): Rajnish Kumar, Anju Sharma, Mohammed Haris Siddiqui and Rajesh Kumar Tiwari
Affiliation:
Keywords: Artificial intelligence, drug designing, drug metabolism, machine learning, pharmacokinetics, prediction.
Abstract: Information about drug metabolism is an essential component of drug development. Modeling the drug metabolism requires identification of the involved enzymes, rate and extent of metabolism, the sites of metabolism etc. There has been continuous attempts in the prediction of metabolism of drugs using artificial intelligence in effort to reduce the attrition rate of drug candidates entering to preclinical and clinical trials. Currently, there are number of predictive models available for metabolism using Support vector machines, Artificial neural networks, Bayesian classifiers etc. There is an urgent need to review their progress so far and address the existing challenges in prediction of metabolism. In this attempt, we are presenting the currently available literature models and some of the critical issues regarding prediction of drug metabolism.
Export Options
About this article
Cite this article as:
Kumar Rajnish, Sharma Anju, Siddiqui Haris Mohammed and Tiwari Kumar Rajesh, Prediction of Metabolism of Drugs using Artificial Intelligence: How far have we reached? , Current Drug Metabolism 2016; 17 (2) . https://dx.doi.org/10.2174/1389200216666151103121352
DOI https://dx.doi.org/10.2174/1389200216666151103121352 |
Print ISSN 1389-2002 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5453 |
Call for Papers in Thematic Issues
Exploring oxidative stress and the anti-oxidant defense system in chronic diseases: therapeutic strategies and future perspective
Ageing is facilitated by oxidative stress (OS), which happens spontaneously. Several studies have demonstrated that OS over an extended period of time has a role in the emergence of several chronic illnesses. Diabetes, cancer, and heart disease are a few examples of these ailments. An imbalance between the body's antioxidants ...read more
Interaction between drugs and endocrine diseases
The introduction of highly active antiretroviral therapy accelerated studies and our understanding on the interaction between pharmacological therapies and endocrine diseases. Drugs can precipitate endocrine via different mechanisms, including direct alteration of hormone production and secretion, dysregulation of hormonal axis, effects on hormonal transport, receptor-binding, and cellular signalling. Common drug-induced ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Progress Towards the Development of Anti-Inflammatory Inhibitors of IKKβ
Current Topics in Medicinal Chemistry Recent Advances in the Medicinal Chemistry of Novel Erythromycin- Derivatized Antibiotics
Current Topics in Medicinal Chemistry Formulating the Structural Aspects of Various Benzimidazole Cognates
Current Topics in Medicinal Chemistry Computational Studies of HIV-1 Integrase and its Inhibitors
Current Computer-Aided Drug Design Von Willebrand Factor: Drug and Drug Target
Cardiovascular & Hematological Disorders-Drug Targets Structure Based Design of 11β-HSD1 Inhibitors
Current Pharmaceutical Biotechnology Tachykinin Receptors as Therapeutic Targets in Stress-Related Disorders
Current Pharmaceutical Design Status of Fatty Acids as Skin Penetration Enhancers-A Review
Current Drug Delivery Appropriate Use of Antibiotics for the Management of Respiratory Tract Infections
Infectious Disorders - Drug Targets Systemic and Biophase Bioavailability and Pharmacokinetics of Nanoparticulate Drug Delivery Systems
Current Drug Delivery The Case of Biotech-Derived Product Equivalence: Much Ado About Nothing?
Current Clinical Pharmacology Mobile Phone Based Health Care Technology
Recent Patents on Biomedical Engineering (Discontinued) Muscular Gene Transfer Using Nonviral Vectors
Current Gene Therapy Phospho-eIF4E: A New Target for Acute Myeloid Leukemia
Current Protein & Peptide Science Common SAR Derived from Multiple QSAR Models on Vorinostat Derivatives Targeting HDACs in Tumor Treatment
Current Pharmaceutical Design Development of MLR and SVM Aided QSAR Models to Identify Common SAR of GABA Uptake Herbal Inhibitors used in the Treatment of Schizophrenia
Current Neuropharmacology Allosteric Modulation of Muscarinic Acetylcholine Receptors
Current Neuropharmacology Forecasting of Covid-19 Cases Using Machine Learning Approach
Current Respiratory Medicine Reviews Discovery of Novel <i>N</i>-alkyl 4-anilinofuro[2,3-<i>b</i>]quinoline Derivatives (CIL-102 Derivatives) Against Castration-resistant Human Prostate Cancers
Anti-Cancer Agents in Medicinal Chemistry Diagnosis of Pathogens Using DNA Microarray
Recent Patents on Biotechnology